Detection of CTX-M-type extended-spectrum beta-lactamases among Jordanian clinical isolates of Enterobacteriaceae.

Scand J Infect Dis

From the Microbiology and Immunology Department, Faculty of Medicine, Mu'tah University, Al-Karak , Jordan.

Published: February 2014

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365548.2013.835069DOI Listing

Publication Analysis

Top Keywords

detection ctx-m-type
4
ctx-m-type extended-spectrum
4
extended-spectrum beta-lactamases
4
beta-lactamases jordanian
4
jordanian clinical
4
clinical isolates
4
isolates enterobacteriaceae
4
detection
1
extended-spectrum
1
beta-lactamases
1

Similar Publications

Extended-spectrum β-lactamase-producing from poultry: A review.

Vet World

September 2024

Doctoral Program in Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, Jl. Dr. Ir. H. Soekarno, Kampus C Mulyorejo, Surabaya 60115, East Java, Indonesia.

Extended-spectrum β-lactamases (ESBLs) are β-lactamase enzymes produced by Gram-negative bacterial pathogens that harbor the ESBL genes. In addition, most ESBL genes are plasmid-mediated and usually encode a broader spectrum of antimicrobial resistance, especially to penicillins, first-generation, second-generation, and third-generation cephalosporins, as well as monobactam, such as aztreonam. has become an opportunistic pathogen, especially in poultry, and has been implicated in zoonotic diseases that can be transmitted to humans, resulting in public health problems.

View Article and Find Full Text PDF

Tn-mediated transfer of from to an outbreak clone of .

Microb Genom

October 2024

Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.

Carriage of CTX-M-type extended-spectrum β-lactamase (ESBL) is rare in . During routine surveillance of an endemic ST-621 at a large hospital, isolate MRSN 100690 carrying was cultured from a patient (P2). This was the first detection of this ESBL in the endemic ST-621 lineage.

View Article and Find Full Text PDF
Article Synopsis
  • The ESBL gene was first identified in a clinical blood isolate from Japan in 2021, marked by high resistance to broad-spectrum cephalosporins like ceftazidime and cefepime.
  • The isolate, JARB-RN-0061, belonged to a pathogenic lineage associated with urinary tract infections and had multiple virulence factors on its chromosome.
  • A unique plasmid carried the ESBL gene, sharing high genetic similarity with other plasmids from related strains found in wastewater, raising concerns about the potential spread of antimicrobial resistance in human pathogens.
View Article and Find Full Text PDF

The widespread prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli limits treatment options and is a worldwide problem. This study aimed to investigate the antimicrobial susceptibility and ESBL types of 204 strains of CTX-M-type ESBLsproducing E. coli isolated from 2011 to 2017 in the Chubu region of Japan and to identify factors correlated with susceptibility.

View Article and Find Full Text PDF

Background: Antimicrobial resistance (AMR) is a global threat to infectious disease control, particularly among recently hospitalized children. We sought to determine the prevalence and mitigating factors of resistance in enteric among children discharged from health facilities in western Kenya.

Methods: Between June 2016 and November 2019, children aged 1 to 59 months were enrolled at the point of discharge from the hospital.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!